Immunohistochemical Markers of Soft Tissue Tumors: Pathologic Diagnosis, Genetic Contributions, and Therapeutic Options

Por Parham, David M
Publicado no Anal Chem Insights (2015)

The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Por Rudzinski, Erin R., Anderson, James R., Hawkins, Douglas S., Skapek, Stephen X., Parham, David M., Teot, Lisa A.
Publicado no Arch Pathol Lab Med (2015)

Grading of Non-Rhabdomyosarcoma Soft Tissue Sarcoma in Children and Adolescents: A Comparison of Parameters Used for the FNCLCC and POG systems

Por Khoury, Joseph D., Coffin, Cheryl M., Spunt, Sheri L., Anderson, James R., Meyer, William H., Parham, David M.
Publicado em 2010

Imaging Features of Alveolar Soft Part Sarcoma: A Report from Children's Oncology Group Study ARST0332

Por McCarville, M. Beth, Muzzafar, Sofia, Kao, Simon C., Coffin, Cheryl, Parham, David M., Anderson, James, Spunt, Sheri L.
Publicado no AJR Am J Roentgenol (2014)

MR and CT Imaging of Low Grade Fibromyxoid Sarcoma in Children: A Report from Children’s Oncology Group Study ARST0332

Por Sargar, Kiran, Kao, Simon C, Spunt, Sheri L, Hawkins, Douglas, Parham, David M, Coffin, Cheryl, McCarville, M Beth
Publicado no AJR Am J Roentgenol (2015)

Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III Trial : A Report from the Children’s Oncolog...

Por Barr, Frederic G., Smith, Lynette M., Lynch, James C., Strzelecki, Donna, Parham, David M., Qualman, Stephen J., Breitfeld, Philip P.
Publicado em 2006

The Clinical, Research, and Social Value of Autopsy after Any Cancer Death: A Perspective from the Children's Oncology Group Soft Tissue Sarcoma Committee

Por Spunt, Sheri L., Vargas, Sara O., Coffin, Cheryl M., Skapek, Stephen X., Parham, David M., Darling, Joan, Hawkins, Douglas S., Keller, Charles
Publicado em 2011

Impaired Wnt Signaling in Embryonal Rhabdomyosarcoma Cells from p53/c-fos Double Mutant Mice

Por Singh, Shalini, Vinson, Charles, Gurley, Cathy M., Nolen, Greg T., Beggs, Marjorie L., Nagarajan, Radhakrishnan, Wagner, Erwin F., Parham, David M., Peterson, Charlotte A.
Publicado em 2010

Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children’s Oncology Group

Por Rosenberg, Abby R., Anderson, James R., Lyden, Elizabeth, Rodeberg, David A., Wolden, Suzanne L., Kao, Simon C., Parham, David M., Arndt, Carola, Hawkins, Douglas S
Publicado em 2013

PAX-FOXO1 Fusion Status Drives Unfavorable Outcome for Children With Rhabdomyosarcoma: A Children’s Oncology Group Report

Por Skapek, Stephen X., Anderson, James, Barr, Frederic G., Bridge, Julia A., Gastier-Foster, Julie M., Parham, David M., Rudzinski, Erin R., Triche, Timothy, Hawkins, Douglas S.
Publicado no Pediatr Blood Cancer (2013)

Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With Hig...

Por Weigel, Brenda J., Lyden, Elizabeth, Anderson, James R., Meyer, William H., Parham, David M., Rodeberg, David A., Michalski, Jeff M., Hawkins, Douglas S., Arndt, Carola A.S.
Publicado no J Clin Oncol (2016)

Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Onc...

Por Mascarenhas, Leo, Lyden, Elizabeth R., Breitfeld, Philip P., Walterhouse, David O., Donaldson, Sarah S., Paidas, Charles N., Parham, David M., Anderson, James R., Meyer, William H., Hawkins, Douglas S.
Publicado em 2010

Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma:...

Por Walterhouse, David O., Pappo, Alberto S., Meza, Jane L., Breneman, John C., Hayes-Jordan, Andrea A., Parham, David M., Cripe, Timothy P., Anderson, James R., Meyer, William H., Hawkins, Douglas S.
Publicado em 2014

Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children’s Oncology Gro...

Por Rudzinski, Erin R., Teot, Lisa A., Anderson, James R., Moore, Julie, Bridge, Julia A., Barr, Frederic G., Gastier-Foster, Julie M., Skapek, Stephen X., Hawkins, Douglas S., Parham, David M.
Publicado no Am J Clin Pathol (2013)

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnose...

Por Beverly Raney, R., Walterhouse, David O., Meza, Jane L., Andrassy, Richard J., Breneman, John C., Crist, William M., Maurer, Harold M., Meyer, William H., Parham, David M., Anderson, James R.
Publicado em 2011

Treatment Results for Patients with Localized, Completely Resected (Group I) Alveolar Rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols -III and -IV, 198...

Por Raney, R. Beverly, Anderson, James R., Brown, Kenneth L. B., Huh, Winston W., Maurer, Harold M., Meyer, William H., Parham, David M., Rodeberg, David A., Wolden, Suzanne L., Donaldson, Sarah S.
Publicado em 2010

Histologic and Clinical Characteristics Can Guide Staging Evaluations for Children and Adolescents With Rhabdomyosarcoma: A Report From the Children's Oncology Group Soft Tissue Sa...

Por Weiss, Aaron R., Lyden, Elizabeth R., Anderson, James R., Hawkins, Douglas S., Spunt, Sheri L., Walterhouse, David O., Wolden, Suzanne L., Parham, David M., Rodeberg, David A., Kao, Simon C., Womer, Richard B.
Publicado em 2013

Myogenin, AP2β, NOS-1 and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma

Por Rudzinski, Erin R., Anderson, James R., Lyden, Elizabeth R., Bridge, Julia A., Barr, Frederic G., Gastier-Foster, Julie M., Bachmeyer, Karen, Skapek, Stephen X., Hawkins, Douglas S., Teot, Lisa A., Parham, David M.
Publicado em 2014

Histology, Fusion Status and Outcome in Alveolar Rhabdomyosarcoma with Low-Risk Clinical Features: A Report from the Children's Oncology Group

Por Arnold, Michael A., Anderson, James R., Gastier-Foster, Julie M., Barr, Frederic G., Skapek, Stephen X., Hawkins, Douglas S., Raney, R. Beverly, Parham, David M., Teot, Lisa A., Rudzinski, Erin R., Walterhouse, David O.
Publicado no Pediatr Blood Cancer (2016)

Prognostic Significance and Tumor Biology of Regional Lymph Node Disease in Patients With Rhabdomyosarcoma: A Report From the Children's Oncology Group

Por Rodeberg, David A., Garcia-Henriquez, Norbert, Lyden, Elizabeth R., Davicioni, Elai, Parham, David M., Skapek, Stephen X., Hayes-Jordan, Andrea A., Donaldson, Sarah S., Brown, Kenneth L., Triche, Timothy J., Meyer, William H., Hawkins, Douglas S.
Publicado em 2011